Brief: Stratec 9-month Net Income Down At EUR 29.5 Million

Stratec SE

03/11/2022 05:57

Nov 3 (Reuters) - Stratec SE  SBSG.DE :
    * EQS-NEWS: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF
2022
    * STRATEC SE NINE MONTHS SALES 207.7 MILLION EUR
    * STRATEC SE NINE MONTHS ADJUSTED EBIT 38.1 MILLION EUR
VERSUS
48.7 MILLION EUR YEAR AGO
    * STRATEC SE NINE MONTHS ADJUSTED BASIC EARNINGS PER SHARE
2.44
EUR VERSUS 3.35 EUR YEAR AGO
    * STRATEC SE - SIGNIFICANT PRODUCT LAUNCH FOR MOLECULAR
DIAGNOSTICS MARKET LEADER IN Q3 OF 2022 AND WELL-STOCKED
DEVELOPMENT PIPELINE
    * STRATEC SE - 9MTH ADJUSTED EBIT MARGIN OF 18.3% (9M/2021:
21.6%)
AT UPPER END OF TARGET CORRIDOR COMMUNICATED FOR FULL YEAR
    * STRATEC SE - ADJUSTED CONSOLIDATED NET INCOME FOR FIRST
NINE
MONTHS OF 2022 ALSO DECREASED, IN THIS CASE FROM EUR 40.6
MILLION TO EUR 29.5 MILLION.
    * STRATEC SE - FOR 2022, STRATEC STILL EXPECTS TOTAL
INVESTMENTS
IN PROPERTY, PLANT AND EQUIPMENT AND IN INTANGIBLE ASSETS TO
CORRESPOND TO 6.0% TO 8.0% OF SALES (2021: 7.0%).
    * STRATEC SE - STRATEC EXPECTS ITS CONSTANT-CURRENCY SALES
TO
DECREASE BY AROUND 5.0% TO 8.0% IN 2022 FINANCIAL YEAR (NOMINAL
SALES REDUCTION OF 1.0% TO 4.0%).
    * STRATEC SE - ADJUSTED EBIT MARGIN IS STILL FORECAST AT AN
UNCHANGED RANGE OF AROUND 16.5% TO 18.5%.

Source text for Eikon:  ID:nEQ1f9pn9a 
Further company coverage:  SBSG.DE 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))